Literature DB >> 20332367

Hepatitis C virus infection and biological false-positive syphilis tests.

M Augenbraun1, A French, M Glesby, L Sanchez-Keeland, M Young, R Greenblatt, A Sharma.   

Abstract

BACKGROUND: The diagnosis of syphilis requires two-step serological testing. Not infrequently, sensitive screening tests are reactive but are not confirmed by more specific confirmatory tests yielding a biological false positive (BFP). This study sought to describe the prevalence of BFP in a large population of hepatitis C virus (HCV)-infected and uninfected women.
METHODS: A cross-sectional serosurvey of HIV-seropositive and HIV-seronegative women enrolled in the Women's Interagency HIV Study, a multicentre collaborative study of the natural history of HIV in women.
RESULTS: Among HCV-infected women 4% had a BFP compared with 1% among those who were HCV uninfected (odds ratio (OR) 3.3, 95% CI 2.1 to 5.1). Controlling for both HIV infection and a history of intravenous drug use among all tests for syphilis a BFP also occurred more commonly in HCV-infected women compared with HCV-uninfected women (6% vs 1%, OR 7.62, 95% CI 1.9 to 12.5).
CONCLUSION: HCV infection is associated with various effects on immune function including alterations in serological test results. Women with HCV are more likely to have a BFP syphilis test than women without HCV.

Entities:  

Mesh:

Year:  2010        PMID: 20332367      PMCID: PMC2981071          DOI: 10.1136/sti.2009.040360

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  8 in total

Review 1.  Self-report among injecting drug users: a review.

Authors:  S Darke
Journal:  Drug Alcohol Depend       Date:  1998-08-01       Impact factor: 4.492

2.  Association of biologic false-positive reactions for syphilis with human immunodeficiency virus infection.

Authors:  A M Rompalo; R O Cannon; T C Quinn; E W Hook
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

3.  False-positive reaction between syphilis and hepatitis C infection.

Authors:  E Sonmez; I H Ozerol; M Senol; N Kizilkaya; K Sahin; H Ozbilge
Journal:  Isr J Med Sci       Date:  1997-11

4.  The Women's Interagency HIV Study. WIHS Collaborative Study Group.

Authors:  S E Barkan; S L Melnick; S Preston-Martin; K Weber; L A Kalish; P Miotti; M Young; R Greenblatt; H Sacks; J Feldman
Journal:  Epidemiology       Date:  1998-03       Impact factor: 4.822

5.  Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS).

Authors:  Toni Frederick; Pamela Burian; Norah Terrault; Mardge Cohen; Michael Augenbraun; Mary Young; Eric Seaberg; Jessica Justman; Alexandra M Levine; Wendy J Mack; Andrea Kovacs
Journal:  AIDS Patient Care STDS       Date:  2009-11       Impact factor: 5.078

Review 6.  Biologic false-positive serologic tests for syphilis and other serologic abnormalities in autoimmune hemolytic anemia and thrombocytopenic purpura.

Authors:  C L Conley; D M Savarese
Journal:  Medicine (Baltimore)       Date:  1989-03       Impact factor: 1.889

7.  Factors associated with hepatitis C viremia in a large cohort of HIV-infected and -uninfected women.

Authors:  Eva A Operskalski; Wendy J Mack; Howard D Strickler; Audrey L French; Michael Augenbraun; Phyllis C Tien; Maria C Villacres; LaShonda Y Spencer; Marina Degiacomo; Andrea Kovacs
Journal:  J Clin Virol       Date:  2008-02-20       Impact factor: 3.168

8.  Association of hepatitis C virus infection with false-positive tests for syphilis.

Authors:  D L Thomas; A M Rompalo; J Zenilman; D Hoover; E W Hook; T C Quinn
Journal:  J Infect Dis       Date:  1994-12       Impact factor: 5.226

  8 in total
  7 in total

Review 1.  Recent trends in the serologic diagnosis of syphilis.

Authors:  Muhammad G Morshed; Ameeta E Singh
Journal:  Clin Vaccine Immunol       Date:  2014-11-26

2.  Frequency and Characteristics of Biological False-Positive Test Results for Syphilis Reported in Florida and New York City, USA, 2013 to 2017.

Authors:  James Matthias; Ellen J Klingler; Julia A Schillinger; Gayle Keller; Craig Wilson; Thomas A Peterman
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

3.  Serologic Testing for Syphilis: Benefits and Challenges of a Reverse Algorithm.

Authors:  Katherine Soreng; Roma Levy; Yetunde Fakile
Journal:  Clin Microbiol Newsl       Date:  2014-12-15

4.  Seroprevalence of Transfusion Transmissible Infections and Associated Risk Factors in Hospitalized Patients before Transfusion in Jinling Hospital Nanjing University: A Three-Year Retrospective Study.

Authors:  Wei Wang; Xiaojun Kong; Guangchao Zhao; Xuelian Huang; Jun Yuan; Na Li; Xiaonan Zhang; Kaiyun Luo; Jianfeng Luan; Xuzhou Fan
Journal:  Pathogens       Date:  2022-06-20

5.  Canadian Public Health Laboratory Network laboratory guidelines for the use of serological tests (excluding point-of-care tests) for the diagnosis of syphilis in Canada.

Authors:  Paul N Levett; Kevin Fonseca; Raymond Sw Tsang; Kamran Kadkhoda; Bouchra Serhir; Sandra M Radons; Muhammad Morshed
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Jan-Feb       Impact factor: 2.471

6.  Cytokine expression in Treponema pallidum infection.

Authors:  N Kojima; J C Siebert; H Maecker; Y Rosenberg-Hasson; S R Leon; S K Vargas; K A Konda; C F Caceres; J D Klausner
Journal:  J Transl Med       Date:  2019-06-11       Impact factor: 5.531

7.  Is repeated retreatment necessary for HIV-negative serofast early syphilis patients?

Authors:  Yong Liu; Queqiao Bian; Shuhuan Zhang; Jun Wang; Zhenming Wang; Junyue Li
Journal:  Exp Ther Med       Date:  2019-11-08       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.